# A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

> **NCT00733460** · PHASE1 · COMPLETED · sponsor: **Fluoropharma, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** BFPET

## Key facts

- **NCT ID:** NCT00733460
- **Lead sponsor:** Fluoropharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733460, "A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00733460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*